Avrobio | Gastos De Venta Y Administración

Selling And Administration Expenses Cambio Fecha
Adcock Ingram Holdings ZAR 989.77M 27M 2023-06
Akebia Therapeutics USD 25.44M 2.73M 2023-12
Alnylam Pharmaceuticals USD 198.12M 1.05M 2023-12
Bluebird Bio USD 40.7M 354K 2023-09
Celltrion KRW 122.75B 31.97B 2023-12
Cspc Pharmaceutical CNY 2.45B 237.6M 2023-09
Deva Holding AS TRY 462.26M 48.18M 2023-09
Ecofibre AUD 9.89M 2.34M 2023-06
Gilead Sciences USD 1.61B 293M 2023-12
Ionis Pharmaceuticals USD 71.01M 1.06M 2023-12
Kangmei Pharma CNY 199.16M 127.36M 2023-09
Knight Therapeutics CAD 23M 1.01M 2023-09
Laboratorios Farma EUR 54.03M 3.27M 2023-06
Magenta Therapeutics USD 8.72M 3.4M 2023-09
Malin Corporation EUR 2.2M 800K 2023-06
Medical Developments International AUD 22.92M 6.46M 2023-06
Neuren Pharmaceuticals AUD 3.69M 2.98M 2023-06
Organigram Holdings CAD 18.78M 2.93M 2023-03
Ovoca Bio EUR 2.96M 8K 2022-06
Pfizer USD 4.47B 1.27B 2023-12
Pharma Mar EUR 8.89M 2.77M 2023-09
Probiotec AUD 15.11M 1.77M 2023-06
Qiagen NV USD 140.11M 5.41M 2023-09
Roche Holding CHF 6.51B 26M 2023-06
Sarepta Therapeutics USD 120.89M 2.33M 2023-09
Sartorius EUR 207.5M 12.7M 2023-09
Sino Biopharmaceutical CNY 6.44B 814.26M 2023-06
Takeda JPY 252.95B 4.84B 2023-09
Zz Pientze Pharmaceu 227.97M 68.21M 2023-09



Avrobio Gastos De Venta Y Administración - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Apr 2024.